2018-03-08| Asia-Pacific

WuXi NextCODE and Google Cloud Collaborate on Genomics

by GeneOnline
Share To

WuXi NextCODE, a genomic information company, announced a partnership with Google Cloud to integrate its genomic data analysis platforms with the Google genomics and research tools. The partnership was announced at the Healthcare Information and Management Systems Society (HIMSS) annual meeting in Las Vegas this week.

With offices in Shanghai; Cambridge, Massachusetts; and Reykjavik, Iceland, WuXi NextCODE provides comprehensive solutions for managing and applying genomic data to improve healthcare and genomic research. The WuXi NextCODE platform was originally developed at deCODE genetics in Iceland to manage massive collection of genomic data. In 2013, deCODE spun out its branch, NextCODE, to focus on using the existing genomic data to find linkage with disease variants in human genome. NextCODE then was acquired by WuXi AppTec, a China- and US-based open access R&D platform, in 2015, and merged with its Shanghai-based WuXi Genome Center.

After the joint venture between WuXi AppTec and the Mayo Clinic on providing clinical diagnostic solution in China in January, WuXi NextCODE took a step forward to work with the data analysis expert, Google Cloud, to resolve the data-processing challenge scientists encounter in genomics. The partnership includes integration of Google genomics and research tools with WuXi’s platform, Google’s DeepVariant secondary analysis pipeline, and other open-source analysis tools available via Google Cloud.

WuXi NextCODE also plans to launch the first phase of the offering at the Bio-IT World Conference & Expo in Boston in May.


Image Source

© All rights reserved. Collaborate with us:
Related Post
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
Saudi Arabia Reveals Grand Ambition to Become a Global Biotech Powerhouse by 2040
GeneOnline’s Weekly News Highlights: Aug 28-Sept 1
Company Presentations at BIO 2024 Inspire Partnering
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
BIO Releases DEI Survey in Partnership with Korn Ferry
Advancing Healthcare Accessibility and Sustainable Development
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
Scroll to Top